Search Results

The VIBRANT Trial

Comparing bare-nitinol stents to stent grafts in long superficial femoral artery lesions in this unique trial.

By Gary M. Ansel, MD, FACC; Patrick J. Geraghty, MD, FACS; Mark Mewissen, MD; and Michael R. Jaff, DO

Chief Medical Editor's Page

Defeating SFA Disease

By John R. Laird, Jr, MDChief Medical Editor

Stenting in Long, Complex Lesions Is Superior to the “Old Standard”

By Mark W. Mewissen, MD

Infrapopliteal Intervention

By John R. Laird, Jr, MD, Chief Medical Editor

An Interview With Gary Ansel, MD

A top interventional cardiologist shares his insight on the future of SFA treatment and what to expect from VIVA 2005.

By Gary Ansel, MD

An Interview With Mark W. Mewissen, MD

A renowned vascular radiologist shares his wisdom about the state of the practice, SFA stenting, and online education.

By Mark W. Mewissen, MD

Endograft Treatment in the SFA

Current SFA stent graft technology has overcome early shortcomings and carries the potential to become the standard of care in selected patients.

By Mark W. Mewissen, MD

Nitinol Stents in the Femoropopliteal Arterial Segment

One center's experience with the Cordis SMART stent suggests the device should play a larger role in treating this vessel.

By Mark W. Mewissen, MD

Aggressive DVT Management Strategies and Techniques

Experts share their experiences with early intervention using pharmacomechanical thrombectomy and temporary filter placement, which have shown rapid symptom resolution and encouraging outcomes.

By Mark W. Mewissen, MD; Anthony C. Venbrux, MD; and Peter H. Lin, MD

Expanding the Role of Peripheral Endografts

By John R. Laird, Jr, MD, Chief Medical Editor

Long Nitinol Stenting in the Femoropopliteal System

Unintended consequences of nitinol stenting on endovascular treatment of the superficial femoral and popliteal arteries.

By Frank J. Arena, MD, FACC, FSCAI

Covered Stents in Longer Lesions

Peter A. Soukas, MD, discusses the available data, his clinical experiences, and techniques for better outcomes and restenosis prevention.

Endovascular Intervention of Iliofemoral Venous Thrombosis

Is there a role for percutaneous pharmacomechanical thrombectomy?

By Peter H. Lin, MD; Eric Peden, MD; Wei Zhou, MD; and Alan B. Lumsden, MD

Treating Proximal Deep Vein Thrombosis

An aggressive approach favors early thrombus removal to preserve outflow and function of the valves.

By Bo Eklof, MD, PhD, and Karthikeshwar Kasirajan, MD